Live from ASH 2024 | First Dataset of Olverembatinib as Second-Line Therapy in Patients with Non-T315I-Mutant CP-CML Presented in Oral Report
ROCKVILLE, Md. and SUZHOU, China, Dec. 10, 2024 /PRNewswire/ — Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing, and commercializing therapies to address global unmet medical needs primarily for malignancies, today announced that Prof. Weiming
Live from ASH 2024 | 1.5-Year Follow-Up Data from a Global Study of Olverembatinib Reaffirms Potential in Overcoming Resistance/Intolerance to Ponatinib or Asciminib
ROCKVILLE, Md. and SUZHOU, China, Dec. 10, 2024 /PRNewswire/ — Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing, and commercializing therapies to address global unmet medical needs primarily for malignancies, today announced that it has released
Live from ASH 2024 | Ascentage Pharma’s Bcl-2 Inhibitor Lisaftoclax in Combinations Demonstrates Potential Clinical Benefit in Patients with Prior Exposure to Venetoclax
ROCKVILLE, Md. and SUZHOU, China, Dec. 10, 2024 /PRNewswire/ — Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing, and commercializing therapies to address global unmet medical needs primarily for malignancies, today announced that it has release
Picus Advances Automated Penetration Testing to Provide Comprehensive Adversarial Exposure Validation
Picus provides automated pentesting alongside attack path mapping to identify and validate critical cybersecurity risks. SAN FRANCISCO, Dec. 10, 2024 /PRNewswire/ — Picus Security, the security validation company, today announced new innovations to its Attack Path Validation (APV) product. Th
Emmes adds new role as it looks to expand government footprint
Bryan Patterson to lead as Senior Vice President of Government Business Development & Capture ROCKVILLE, Md., Dec. 10, 2024 /PRNewswire/ — Emmes®, part of Emmes Group®, a leading specialty tech and AI-enabled global contract research organization (CRO), today announced the appointment
Premier Publishers A360, Sundial Media Group, USNews and MediaCorp Select ArcSpan AMS Platform to Enhance Audience Monetization
NEW YORK, Dec. 10, 2024 /PRNewswire/ — ArcSpan Technologies, a leader in AI-powered audience monetization solutions for global publishers, is excited to announce new partnerships with leading publishers A360, Sundial Media Group, USNews, and MediaCorp. These industry leaders have adopted ArcSp
Portland Public Schools Selects YouScience to Empower Students with Career-Ready Skills Through Career and Technical Education (CTE) Programs
New partnership brings aptitude-driven career insights to Oregon’s largest school district AMERICAN FORK, Utah, Dec. 10, 2024 /PRNewswire/ — Today, YouScience®, the leading technology provider dedicated to solving the skills gap crisis for students and employers, announces a partners
Theranica Advances Migraine Care in 2024 Supported by New Research, an Expanded Indication, a new Chief Medical Officer, and Broader Insurance Coverage
The Nerivio® REN wearable is redefining pediatric migraine care as the only migraine-specific preventive therapy for children under the age of 12. BRIDGEWATER, N.J. and NETANYA, Israel, Dec. 10, 2024 /PRNewswire/ — Theranica, a prescribed neuromodulation therapeutics company, today announced
Stout Acquires DebtX Analytics, Expanding Capabilities in Loan Portfolio Valuation, Stress Testing, and CECL Analysis
CHICAGO, Dec. 10, 2024 /PRNewswire/ — Stout, a global advisory firm, is pleased to announce the acquisition of DebtX Analytics, Inc., a provider of loan valuation services and stress testing to banks, insurance companies, private equity and government agencies. This strategic acquisition enhan
Startek® Honduras earns Dragon Award ‘Generation Y-Z’ and celebrates leadership recognition
Fostering innovation, inclusion and excellence across generations TEGUCIGALPA, Honduras, Dec. 10, 2024 /PRNewswire/ — Startek® a digital-first global customer experience (CX) solutions provider, is delighted to announce two significant honors that underscore its unwavering commitment to excel
